8-K

Company

Bicara Therapeutics Inc.

Filed

September 16, 2024

Period of Report

September 12, 2024

Accession Number

0001193125-24-219617

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →